PEN
HealthcarePenumbra, Inc.
$336.18+0.72 (+0.21%)
Prev Close
$334.99
Open
$336.33
High
$337.00
Low
$334.90
Volume
256.2K
Market Cap
$13.19B
P/E
74.27
Div Yield
—
Over the past 12 months, insider activity at Penumbra, Inc. (PEN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 52 insider sales totaling $80.38M. The most recent insider transaction was by Yuen Maggie (officer: Chief Financial Officer), who sold $832.5K worth of shares on Mar 4, 2026. Penumbra, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $13.19B.
Buys (12M)
0
$0.00
Sells (12M)
52
$80.38M
Net Activity
Net Seller
$80.38M
Active Insiders
9
last 12 mo
PEN Price Chart
PEN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Yuen Maggie | officer: Chief Financial Officer | Sell | 2,432 | $342.30 | $832.5K | 18,353 |
| Feb 18, 2026↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 482 | $339.30 | $163.5K | 0 |
| Feb 13, 2026↗ | Narayan Shruthi | President | Sell | 705 | $339.30 | $239.2K | 0 |
| Feb 13, 2026↗ | Shiu Lambert | Chief Accounting Officer | Sell | 412 | $339.30 | $139.8K | 0 |
| Feb 13, 2026↗ | Yuen Maggie | Chief Financial Officer | Sell | 481 | $339.30 | $163.2K | 0 |
| Jan 8, 2026↗ | Grewal Harpreet | director | Sell | 186 | $312.64 | $58.2K | 8,230 |
| Jan 6, 2026↗ | Wilder Thomas | director | Sell | 186 | $310.72 | $57.8K | 0 |
| Dec 15, 2025↗ | Bose Arani | Director | Sell | 15,000 | $308.82 | $4.63M | 271,432 |
| Dec 9, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 300 | $300.13 | $90.0K | 63,836 |
| Dec 3, 2025↗ | Grewal Harpreet | Director | Sell | 100 | $292.98 | $29.3K | 8,416 |
| Dec 3, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $294.94 | $177.0K | 64,642 |
| Nov 26, 2025↗ | Bose Arani | Director | Sell | 7,500 | $300.19 | $2.25M | 275,261 |
| Nov 26, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 1,800 | $300.06 | $540.1K | 64,736 |
| Nov 25, 2025↗ | Bose Arani | Director | Sell | 7,500 | $290.56 | $2.18M | 282,923 |
| Nov 12, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $266.98 | $160.2K | 64,246 |
| Nov 6, 2025↗ | Grewal Harpreet | Director | Sell | 186 | $227.58 | $42.3K | 8,516 |
| Oct 3, 2025↗ | Grewal Harpreet | Director | Sell | 186 | $248.61 | $46.2K | 8,702 |
| Oct 3, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $249.70 | $149.8K | 64,833 |
| Oct 3, 2025↗ | Wilder Thomas | Director | Sell | 186 | $253.93 | $47.2K | 186 |
| Sep 4, 2025↗ | Elsesser Adam | CEO | Sell | 15,800 | $269.65 | $4.26M | 195,909 |
| Sep 4, 2025↗ | Grewal Harpreet | Director | Sell | 186 | $272.19 | $50.6K | 8,888 |
| Sep 4, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $270.58 | $162.3K | 65,235 |
| Aug 22, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,900 | $254.53 | $4.05M | 185,721 |
| Aug 15, 2025↗ | Bose Arani | Director | Sell | 12,000 | $250.65 | $3.01M | 3,455 |
| Aug 15, 2025↗ | Yuen Maggie | Chief Financial Officer | Sell | 2,000 | $250.00 | $500.0K | 12,943 |
| Aug 13, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $238.94 | $143.4K | 66,039 |
| Aug 13, 2025↗ | Wilder Thomas | Director | Sell | 372 | $240.16 | $89.3K | 372 |
| Aug 8, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,030 | $238.20 | $3.82M | 171,748 |
| Jul 25, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,150 | $233.16 | $3.77M | 158,779 |
| Jul 11, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,985 | $243.75 | $3.90M | 149,022 |
| Jul 3, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $252.70 | $151.6K | 66,649 |
| Jun 27, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,890 | $253.40 | $4.03M | 135,887 |
| Jun 18, 2025↗ | O'Rourke Bridget | Director | Sell | 50 | $259.78 | $13.0K | 5,373 |
| Jun 13, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,910 | $253.67 | $4.04M | 124,965 |
| Jun 4, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $258.17 | $154.9K | 65,260 |
| May 30, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,300 | $267.91 | $4.37M | 113,489 |
| May 16, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,600 | $298.22 | $4.95M | 103,113 |
| May 16, 2025↗ | O'Rourke Bridget | Director | Sell | 100 | $286.15 | $28.6K | 5,423 |
| May 14, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 900 | $298.55 | $268.7K | 66,193 |
| May 9, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,650 | $289.37 | $4.82M | 88,537 |
| May 6, 2025↗ | Yuen Maggie | Chief Financial Officer | Sell | 2,000 | $299.01 | $598.0K | 13,957 |
| Apr 29, 2025↗ | Bose Arani | Director | Sell | 12,000 | $298.73 | $3.58M | 314,501 |
| Apr 25, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $300.01 | $180.0K | 66,159 |
| Apr 18, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,560 | $274.35 | $4.54M | 78,227 |
| Apr 17, 2025↗ | O'Rourke Bridget | Director | Sell | 50 | $271.21 | $13.6K | 5,523 |
| Apr 4, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,565 | $272.24 | $4.51M | 67,702 |
| Apr 4, 2025↗ | Wilder Thomas | Director | Sell | 360 | $266.93 | $96.1K | 4,692 |
| Apr 2, 2025↗ | Grewal Harpreet | Director | Sell | 200 | $267.17 | $53.4K | 9,074 |
| Apr 2, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $269.11 | $161.5K | 66,947 |
| Apr 2, 2025↗ | Wilder Thomas | Director | Sell | 360 | $264.58 | $95.2K | 4,533 |
Showing 1–50 of 170
1 / 4
PEN Insider Buying Activity
The following table shows recent insider purchases of Penumbra, Inc. (PEN) stock reported via SEC Form 4 filings.
No insider buying activity found for PEN in the last 12 months.
PEN Insider Selling Activity
The following table shows recent insider sales of Penumbra, Inc. (PEN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | Yuen Maggie | officer: Chief Financial Officer | Sell | 2,432 | $342.30 | $832.5K | 18,353 |
| Feb 18, 2026↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 482 | $339.30 | $163.5K | 0 |
| Feb 13, 2026↗ | Narayan Shruthi | President | Sell | 705 | $339.30 | $239.2K | 0 |
| Feb 13, 2026↗ | Shiu Lambert | Chief Accounting Officer | Sell | 412 | $339.30 | $139.8K | 0 |
| Feb 13, 2026↗ | Yuen Maggie | Chief Financial Officer | Sell | 481 | $339.30 | $163.2K | 0 |
| Jan 8, 2026↗ | Grewal Harpreet | director | Sell | 186 | $312.64 | $58.2K | 8,230 |
| Jan 6, 2026↗ | Wilder Thomas | director | Sell | 186 | $310.72 | $57.8K | 0 |
| Dec 15, 2025↗ | Bose Arani | Director | Sell | 15,000 | $308.82 | $4.63M | 271,432 |
| Dec 9, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 300 | $300.13 | $90.0K | 63,836 |
| Dec 3, 2025↗ | Grewal Harpreet | Director | Sell | 100 | $292.98 | $29.3K | 8,416 |
| Dec 3, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $294.94 | $177.0K | 64,642 |
| Nov 26, 2025↗ | Bose Arani | Director | Sell | 7,500 | $300.19 | $2.25M | 275,261 |
| Nov 26, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 1,800 | $300.06 | $540.1K | 64,736 |
| Nov 25, 2025↗ | Bose Arani | Director | Sell | 7,500 | $290.56 | $2.18M | 282,923 |
| Nov 12, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $266.98 | $160.2K | 64,246 |
| Nov 6, 2025↗ | Grewal Harpreet | Director | Sell | 186 | $227.58 | $42.3K | 8,516 |
| Oct 3, 2025↗ | Grewal Harpreet | Director | Sell | 186 | $248.61 | $46.2K | 8,702 |
| Oct 3, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $249.70 | $149.8K | 64,833 |
| Oct 3, 2025↗ | Wilder Thomas | Director | Sell | 186 | $253.93 | $47.2K | 186 |
| Sep 4, 2025↗ | Elsesser Adam | CEO | Sell | 15,800 | $269.65 | $4.26M | 195,909 |
| Sep 4, 2025↗ | Grewal Harpreet | Director | Sell | 186 | $272.19 | $50.6K | 8,888 |
| Sep 4, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $270.58 | $162.3K | 65,235 |
| Aug 22, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,900 | $254.53 | $4.05M | 185,721 |
| Aug 15, 2025↗ | Bose Arani | Director | Sell | 12,000 | $250.65 | $3.01M | 3,455 |
| Aug 15, 2025↗ | Yuen Maggie | Chief Financial Officer | Sell | 2,000 | $250.00 | $500.0K | 12,943 |
| Aug 13, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $238.94 | $143.4K | 66,039 |
| Aug 13, 2025↗ | Wilder Thomas | Director | Sell | 372 | $240.16 | $89.3K | 372 |
| Aug 8, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,030 | $238.20 | $3.82M | 171,748 |
| Jul 25, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,150 | $233.16 | $3.77M | 158,779 |
| Jul 11, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,985 | $243.75 | $3.90M | 149,022 |
| Jul 3, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $252.70 | $151.6K | 66,649 |
| Jun 27, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,890 | $253.40 | $4.03M | 135,887 |
| Jun 18, 2025↗ | O'Rourke Bridget | Director | Sell | 50 | $259.78 | $13.0K | 5,373 |
| Jun 13, 2025↗ | Elsesser Adam | CEO and President | Sell | 15,910 | $253.67 | $4.04M | 124,965 |
| Jun 4, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $258.17 | $154.9K | 65,260 |
| May 30, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,300 | $267.91 | $4.37M | 113,489 |
| May 16, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,600 | $298.22 | $4.95M | 103,113 |
| May 16, 2025↗ | O'Rourke Bridget | Director | Sell | 100 | $286.15 | $28.6K | 5,423 |
| May 14, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 900 | $298.55 | $268.7K | 66,193 |
| May 9, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,650 | $289.37 | $4.82M | 88,537 |
| May 6, 2025↗ | Yuen Maggie | Chief Financial Officer | Sell | 2,000 | $299.01 | $598.0K | 13,957 |
| Apr 29, 2025↗ | Bose Arani | Director | Sell | 12,000 | $298.73 | $3.58M | 314,501 |
| Apr 25, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $300.01 | $180.0K | 66,159 |
| Apr 18, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,560 | $274.35 | $4.54M | 78,227 |
| Apr 17, 2025↗ | O'Rourke Bridget | Director | Sell | 50 | $271.21 | $13.6K | 5,523 |
| Apr 4, 2025↗ | Elsesser Adam | CEO and President | Sell | 16,565 | $272.24 | $4.51M | 67,702 |
| Apr 4, 2025↗ | Wilder Thomas | Director | Sell | 360 | $266.93 | $96.1K | 4,692 |
| Apr 2, 2025↗ | Grewal Harpreet | Director | Sell | 200 | $267.17 | $53.4K | 9,074 |
| Apr 2, 2025↗ | Roberts Johanna | EVP, Gen. Counsel & Secretary | Sell | 600 | $269.11 | $161.5K | 66,947 |
| Apr 2, 2025↗ | Wilder Thomas | Director | Sell | 360 | $264.58 | $95.2K | 4,533 |
PEN Insiders
Similar Stocks to PEN
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B
PODD
Insulet Corporation
$219.84-6.34%
$15.48B